BIMBX
Price
$10.36
Change
-$0.01 (-0.10%)
Updated
May 9 closing price
Net Assets
7.64B
GMMPX
Price
$10.91
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
58.17M
Ad is loading...

BIMBX vs GMMPX

Header iconBIMBX vs GMMPX Comparison
Open Charts BIMBX vs GMMPXBanner chart's image
BlackRock Systematic Multi-Strat Instl
Price$10.36
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets7.64B
Goldman Sachs Multi-Strategy Alts P
Price$10.91
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets58.17M
BIMBX vs GMMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIMBX vs. GMMPX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIMBX is a Hold and GMMPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BIMBX has more cash in the bank: 7.64B vs. GMMPX (58.2M). GMMPX pays higher dividends than BIMBX: GMMPX (4.83) vs BIMBX (3.95). BIMBX was incepted earlier than GMMPX: BIMBX (10 years) vs GMMPX (7 years). GMMPX (2.73) is less costly to investors than BIMBX (0.93). GMMPX has a lower initial minimum investment than BIMBX: GMMPX (0) vs BIMBX (2000000). GMMPX annual gain was more profitable for investors over the last year : 8.92 vs. BIMBX (6.23). BIMBX return over 5 years is better than : 19.86 vs. GMMPX (13.92).
BIMBXGMMPXBIMBX / GMMPX
Total Expense Ratio0.930.84111%
Annual Report Gross Expense Ratio0.932.7334%
Fund Existence10 years7 years-
Gain YTD2.6736.54341%
Front LoadN/AN/A-
Min. Initial Investment20000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.64B58.2M13,129%
Annual Yield % from dividends3.954.8382%
Returns for 1 year6.238.9270%
Returns for 3 years16.534.08405%
Returns for 5 years19.8613.92143%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIOTX9.24N/A
N/A
Issachar I
CGWRX63.86N/A
N/A
Columbia Large Cap Growth R
FTSIX35.17N/A
N/A
FullerThaler Behvrl S-M Cor Eq Instl
MVISX38.84N/A
N/A
Patient Opportunity IS
VVSGX15.32-0.06
-0.39%
VALIC Company I Small Cap Growth